Results 181 to 190 of about 579,295 (296)
Effect of perioperative remote ischemic conditioning on myocardial injury in patients with unstable angina undergoing percutaneous coronary intervention: protocol of a multicenter, randomized, double-blind clinical trial. [PDF]
Xia L+7 more
europepmc +1 more source
Medicaid Expansion Among Nonelderly Adults and Cardiovascular Disease: Efficiency Vs. Equity
Policy Points Evidence suggests Medicaid expansion has improved cardiovascular disease (CVD) outcomes, especially among those of lower socioeconomic status. However, less is known about the cost‐effectiveness of Medicaid in achieving these outcomes and reducing CVD disparities.
LUKE E. BARRY+3 more
wiley +1 more source
Myocardial Ischaemic Syndromes: Shifting from a Coronary-centric to a Substrate-based Nomenclature is More Accurate and Inclusive. [PDF]
Boden WE+6 more
europepmc +1 more source
ABSTRACT Objective To externally validate the current Monash Health criteria for rapid rule‐out (RRO) of myocardial infarction (MI) at a tertiary cardiac emergency (CE). Methods All patients with suspected MI at the Victorian Heart Hospital (VHH) CE from April to June 2023 were eligible.
Robert Meek+8 more
wiley +1 more source
Prognostic value of the neutrophil to lymphocyte ratio for cardiovascular diseases: research progress. [PDF]
Zhang X, Li D, Du Y.
europepmc +1 more source
While the etiology of race differences in mobility is multifactorial, our data indicate that muscle mitochondrial respiration and cardiorespiratory fitness may contribute to the slower walking speed of individuals who identify as Black compared to White.
Paul M. Coen+12 more
wiley +1 more source
Correlation of Serum Homocysteine Levels With Various Types of Coronary Syndromes (CS) and In-Hospital Mortality - A Multicenter Study. [PDF]
Ullah H+28 more
europepmc +1 more source
Abstract Aims Diabetes mellitus remains a prevalent condition worldwide and a significant risk factor for atherosclerotic cardiovascular disease. Recent evidence suggests the use of glucose‐lowering therapies with cardiovascular benefit in optimising the cardiometabolic profile of patients with type 2 diabetes mellitus.
Muhammad Usman Shah+6 more
wiley +1 more source